Cancer BiologybioRxivPreprint
Integrated in silico and in vitro approaches identify a HSP90 drug vulnerability axis in t(7;12) infant leukemia stem-like cells
Ylenia Cicirò, Denise Ragusa, Emily M. Johnson…·Cristina Pina
The paper identifies HSP90 inhibitors as potential therapies for t(7;12)-AML by combining computational drug screening with in vitro experiments.
DOI 10.1101/2025.09.06.674620